AlphaFold predicted structure
HECW2 · Q9P2P5

Mean pLDDT
60.4/ 100
Low
1,572 residues
Confidence breakdown
- Very high(≥ 90)21%
- Confident(70–90)26%
- Low(50–70)7%
- Very low(< 50)46%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
HECT, C2 and WW domain containing E3 ubiquitin protein ligase 2
Annotations refreshed 10 hours ago.
Diagnostic Grade (Green)
Childhood onset dystonia, chorea or related movement disorder
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownDDG2P
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownEarly onset or syndromic epilepsy
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownIntellectual disability
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownFetal anomalies
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownneurodevelopmental disorder with hypotonia, seizures, and absent language
hereditary disease
complex neurodevelopmental disorder
neurodegenerative disease
Abnormality of the nervous system
neurodevelopmental disorder with hypotonia and seizures
liver disorder
poisoning
generalized dystonia
hypertrophic cardiomyopathy
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
E3 ubiquitin-protein ligase HECW2
E3 ubiquitin-protein ligase that mediates ubiquitination of TP73. Acts to stabilize TP73 and enhance activation of transcription by TP73 (PubMed:12890487). Involved in the regulation of mitotic metaphase/anaphase transition (PubMed:24163370)
HECW2 · Q9P2P5

Mean pLDDT
60.4/ 100
Low
1,572 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0